NEOPLASMS OF THE LUNG: Edited by Alan M. Fein and David E. OstManagement of malignant pleural effusionsDipper, Alexandra; Bhatnagar, Rahul; Maskell, NickAuthor Information Academic Respiratory Unit, University of Bristol, Bristol, UK Correspondence to Nick Maskell, BM, BS, Academic Respiratory Unit, Learning and Research Building (Level 2), Southmead Hospital, Bristol BS10 5NB, UK. Tel: +44 117 950 5050; e-mail: [email protected] Current Opinion in Pulmonary Medicine: July 2020 - Volume 26 - Issue 4 - p 341-345 doi: 10.1097/MCP.0000000000000685 Buy Metrics Abstract Purpose of review Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options. This article provides a summary of the most up-to-date evidence in this area. Recent findings Recent publications have demonstrated comparable pleurodesis outcomes of talc slurry to talc poudrage and explore strategies to combine the advantages of indwelling pleural catheters (IPCs) with a chemical pleurodesis. A daily IPC drainage regime improves the chances of pleurodesis success and early IPC removal in patients without significant trapped lung. Summary MPE is a diverse condition, with no one strategy representing the ‘best’ approach for all. Management decisions should be made in conjunction with the patient, taking their views and preferences into consideration. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.